Cubist Systematic Strategies’s Collegium Pharmaceutical COLL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-92,992
| Closed | -$3.61M | – | 1667 |
|
|
2024
Q1 | $3.61M | Buy |
92,992
+20,663
| +29% | +$802K | 0.02% | 637 |
|
|
2023
Q4 | $2.23M | Sell |
72,329
-5,826
| -7% | -$179K | 0.01% | 775 |
|
|
2023
Q3 | $1.75M | Buy |
+78,155
| New | +$1.75M | 0.01% | 836 |
|
|
2023
Q2 | – | Sell |
-196,096
| Closed | -$4.7M | – | 2399 |
|
|
2023
Q1 | $4.7M | Buy |
+196,096
| New | +$4.7M | 0.03% | 640 |
|
|
2022
Q4 | – | Sell |
-65,578
| Closed | -$1.05M | – | 3317 |
|
|
2022
Q3 | $1.05M | Buy |
+65,578
| New | +$1.05M | 0.01% | 2037 |
|
|
2022
Q2 | – | Sell |
-74,897
| Closed | -$1.53M | – | 3841 |
|
|
2022
Q1 | $1.53M | Buy |
74,897
+45,470
| +155% | +$926K | 0.01% | 1706 |
|
|
2021
Q4 | $550K | Sell |
29,427
-11,678
| -28% | -$218K | 0.01% | 2374 |
|
|
2021
Q3 | $811K | Sell |
41,105
-7,620
| -16% | -$150K | 0.01% | 1686 |
|
|
2021
Q2 | $1.15M | Sell |
48,725
-6,796
| -12% | -$161K | 0.01% | 1462 |
|
|
2021
Q1 | $1.32M | Buy |
55,521
+33,222
| +149% | +$787K | 0.02% | 1344 |
|
|
2020
Q4 | $447K | Sell |
22,299
-10,295
| -32% | -$206K | 0.01% | 1831 |
|
|
2020
Q3 | $679K | Buy |
32,594
+742
| +2% | +$15.5K | 0.01% | 1562 |
|
|
2020
Q2 | $557K | Sell |
31,852
-37,269
| -54% | -$652K | 0.01% | 1533 |
|
|
2020
Q1 | $1.13M | Buy |
69,121
+37,884
| +121% | +$619K | 0.03% | 754 |
|
|
2019
Q4 | $643K | Buy |
+31,237
| New | +$643K | 0.01% | 1401 |
|
|
2019
Q2 | – | Sell |
-33,248
| Closed | -$503K | – | 2468 |
|
|
2019
Q1 | $503K | Buy |
+33,248
| New | +$503K | 0.02% | 1196 |
|
|
2018
Q4 | – | Sell |
-10,309
| Closed | -$152K | – | 2081 |
|
|
2018
Q3 | $152K | Buy |
10,309
+1,383
| +15% | +$20.4K | 0.01% | 1477 |
|
|
2018
Q2 | $213K | Buy |
+8,926
| New | +$213K | 0.01% | 1310 |
|